Clinical and Investigative Medicine This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Hats Off to the CIM Reviewers of 2023
Clin Invest Med. 2023 Dec;46(4):E02. doi: 10.3138/cim.v46i4e02.NO ABSTRACTPMID:38330182 | DOI:10.3138/cim.v46i4e02 (Source: Clinical and Investigative Medicine)
Source: Clinical and Investigative Medicine - February 8, 2024 Category: Biomedical Science Authors: Robert Bortolussi Source Type: research

Efficacy and Safety of Glucocorticoid in the Treatment of Acute Respiratory Distress Syndrome caused by Covid-19: A Systematic Review and Meta-Analysis
CONCLUSIONS: Although methylprednisolone may reduce all-cause mortality from ARDS caused by COVID-19, this effect was not found with other types of glucocorticoids. At the same time, glucocorticoid use was associ-ated with more ventilator-free days, without increasing the incidence of hyperglycemic events or VAP. Con-sidering that almost all of the included studies were retrospective cohort studies, more RCTs are needed to confirm these findings.PMID:38330183 | DOI:10.3138/cim.v46i4e03 (Source: Clinical and Investigative Medicine)
Source: Clinical and Investigative Medicine - February 8, 2024 Category: Biomedical Science Authors: Xiangyang Jiang Changyun Zhao Weihang Hu Difan Lu Changqin Chen Shijin Gong Jing Yan Wenchao Mao Source Type: research

Changes to CIM Are on the Way
Clin Invest Med. 2023 Dec;46(4):E01. doi: 10.3138/cim.v46i4e01.NO ABSTRACTPMID:38330184 | DOI:10.3138/cim.v46i4e01 (Source: Clinical and Investigative Medicine)
Source: Clinical and Investigative Medicine - February 8, 2024 Category: Biomedical Science Authors: Robert Bortolussi Source Type: research

Hats Off to the CIM Reviewers of 2023
Clin Invest Med. 2023 Dec;46(4):E02. doi: 10.3138/cim.v46i4e02.NO ABSTRACTPMID:38330182 | DOI:10.3138/cim.v46i4e02 (Source: Clinical and Investigative Medicine)
Source: Clinical and Investigative Medicine - February 8, 2024 Category: Biomedical Science Authors: Robert Bortolussi Source Type: research

Efficacy and Safety of Glucocorticoid in the Treatment of Acute Respiratory Distress Syndrome caused by Covid-19: A Systematic Review and Meta-Analysis
CONCLUSIONS: Although methylprednisolone may reduce all-cause mortality from ARDS caused by COVID-19, this effect was not found with other types of glucocorticoids. At the same time, glucocorticoid use was associ-ated with more ventilator-free days, without increasing the incidence of hyperglycemic events or VAP. Con-sidering that almost all of the included studies were retrospective cohort studies, more RCTs are needed to confirm these findings.PMID:38330183 | DOI:10.3138/cim.v46i4e03 (Source: Clinical and Investigative Medicine)
Source: Clinical and Investigative Medicine - February 8, 2024 Category: Biomedical Science Authors: Xiangyang Jiang Changyun Zhao Weihang Hu Difan Lu Changqin Chen Shijin Gong Jing Yan Wenchao Mao Source Type: research

Changes to CIM Are on the Way
Clin Invest Med. 2023 Dec;46(4):E01. doi: 10.3138/cim.v46i4e01.NO ABSTRACTPMID:38330184 | DOI:10.3138/cim.v46i4e01 (Source: Clinical and Investigative Medicine)
Source: Clinical and Investigative Medicine - February 8, 2024 Category: Biomedical Science Authors: Robert Bortolussi Source Type: research

Hats Off to the CIM Reviewers of 2023
Clin Invest Med. 2023 Dec;46(4):E02. doi: 10.3138/cim.v46i4e02.NO ABSTRACTPMID:38330182 | DOI:10.3138/cim.v46i4e02 (Source: Clinical and Investigative Medicine)
Source: Clinical and Investigative Medicine - February 8, 2024 Category: Biomedical Science Authors: Robert Bortolussi Source Type: research

Efficacy and Safety of Glucocorticoid in the Treatment of Acute Respiratory Distress Syndrome caused by Covid-19: A Systematic Review and Meta-Analysis
CONCLUSIONS: Although methylprednisolone may reduce all-cause mortality from ARDS caused by COVID-19, this effect was not found with other types of glucocorticoids. At the same time, glucocorticoid use was associ-ated with more ventilator-free days, without increasing the incidence of hyperglycemic events or VAP. Con-sidering that almost all of the included studies were retrospective cohort studies, more RCTs are needed to confirm these findings.PMID:38330183 | DOI:10.3138/cim.v46i4e03 (Source: Clinical and Investigative Medicine)
Source: Clinical and Investigative Medicine - February 8, 2024 Category: Biomedical Science Authors: Xiangyang Jiang Changyun Zhao Weihang Hu Difan Lu Changqin Chen Shijin Gong Jing Yan Wenchao Mao Source Type: research

Changes to CIM Are on the Way
Clin Invest Med. 2023 Dec;46(4):E01. doi: 10.3138/cim.v46i4e01.NO ABSTRACTPMID:38330184 | DOI:10.3138/cim.v46i4e01 (Source: Clinical and Investigative Medicine)
Source: Clinical and Investigative Medicine - February 8, 2024 Category: Biomedical Science Authors: Robert Bortolussi Source Type: research

Hats Off to the CIM Reviewers of 2023
Clin Invest Med. 2023 Dec;46(4):E02. doi: 10.3138/cim.v46i4e02.NO ABSTRACTPMID:38330182 | DOI:10.3138/cim.v46i4e02 (Source: Clinical and Investigative Medicine)
Source: Clinical and Investigative Medicine - February 8, 2024 Category: Biomedical Science Authors: Robert Bortolussi Source Type: research

Efficacy and Safety of Glucocorticoid in the Treatment of Acute Respiratory Distress Syndrome caused by Covid-19: A Systematic Review and Meta-Analysis
CONCLUSIONS: Although methylprednisolone may reduce all-cause mortality from ARDS caused by COVID-19, this effect was not found with other types of glucocorticoids. At the same time, glucocorticoid use was associ-ated with more ventilator-free days, without increasing the incidence of hyperglycemic events or VAP. Con-sidering that almost all of the included studies were retrospective cohort studies, more RCTs are needed to confirm these findings.PMID:38330183 | DOI:10.3138/cim.v46i4e03 (Source: Clinical and Investigative Medicine)
Source: Clinical and Investigative Medicine - February 8, 2024 Category: Biomedical Science Authors: Xiangyang Jiang Changyun Zhao Weihang Hu Difan Lu Changqin Chen Shijin Gong Jing Yan Wenchao Mao Source Type: research

Changes to CIM Are on the Way
Clin Invest Med. 2023 Dec;46(4):E01. doi: 10.3138/cim.v46i4e01.NO ABSTRACTPMID:38330184 | DOI:10.3138/cim.v46i4e01 (Source: Clinical and Investigative Medicine)
Source: Clinical and Investigative Medicine - February 8, 2024 Category: Biomedical Science Authors: Robert Bortolussi Source Type: research

Hats Off to the CIM Reviewers of 2023
Clin Invest Med. 2023 Dec;46(4):E02. doi: 10.3138/cim.v46i4e02.NO ABSTRACTPMID:38330182 | DOI:10.3138/cim.v46i4e02 (Source: Clinical and Investigative Medicine)
Source: Clinical and Investigative Medicine - February 8, 2024 Category: Biomedical Science Authors: Robert Bortolussi Source Type: research

Efficacy and Safety of Glucocorticoid in the Treatment of Acute Respiratory Distress Syndrome caused by Covid-19: A Systematic Review and Meta-Analysis
CONCLUSIONS: Although methylprednisolone may reduce all-cause mortality from ARDS caused by COVID-19, this effect was not found with other types of glucocorticoids. At the same time, glucocorticoid use was associ-ated with more ventilator-free days, without increasing the incidence of hyperglycemic events or VAP. Con-sidering that almost all of the included studies were retrospective cohort studies, more RCTs are needed to confirm these findings.PMID:38330183 | DOI:10.3138/cim.v46i4e03 (Source: Clinical and Investigative Medicine)
Source: Clinical and Investigative Medicine - February 8, 2024 Category: Biomedical Science Authors: Xiangyang Jiang Changyun Zhao Weihang Hu Difan Lu Changqin Chen Shijin Gong Jing Yan Wenchao Mao Source Type: research

Changes to CIM Are on the Way
Clin Invest Med. 2023 Dec;46(4):E01. doi: 10.3138/cim.v46i4e01.NO ABSTRACTPMID:38330184 | DOI:10.3138/cim.v46i4e01 (Source: Clinical and Investigative Medicine)
Source: Clinical and Investigative Medicine - February 8, 2024 Category: Biomedical Science Authors: Robert Bortolussi Source Type: research